ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pregnancy"

  • Abstract Number: 0238 • ACR Convergence 2021

    The Impact of Preeclampsia on Pregnancies and Infants of Women with Rheumatic Disease

    Megan Milne1, Megan Clowse2, Amanda Eudy1, Congwen Zhao1 and Ben Goldstein1, 1Duke University, Durham, NC, 2Duke University, Chapel Hill, NC

    Background/Purpose: Rheumatic diseases, such as SLE, are associated with serious maternal, pregnancy, and infant complications. The role that preeclampsia plays in these outcomes in women…
  • Abstract Number: 1724 • ACR Convergence 2021

    More Than 50% of Women with Chronic Rheumatic Inflammatory Diseases Present an Unfavorable Pregnancy Outcome: A Descriptive Analysis of the National French Healthcare Database

    Anna Molto1, Barbara Roux2, Diep Tran2, Aya Ajrouche2, nathalie costedoat-Chalumeau3, Elisabeth Elefant4, Vassilis Tsatsaris5, Jeanne Fresson6, Brigitte Bader-Meunier7, Bruno Fautrel8 and Florence Tubach2, 1Rheumatology department, Cochin hospital, APHP, Paris, France, 2CEPHEPI, APHP, Paris, France, 3Inserm DR Paris 5, Paris, France, 4Teratogenic agents refernce center (CRAT) , Hôpital Trousseau, APHP, Paris, France, 5Obstetrics Department, Port Royal Maternity, Cochin Hospital, APHP, Paris, France, 6CHU Nancy, Nancy, France, 7Pediatric Immuno-hematology, Necker Hospital, APHP, Paris, France, 8Pitié Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France

    Background/Purpose: Women with chronic rheumatic inflammatory diseases (CRID, i.e. rheumatoid arthritis (RA) or spondyloarthritis (SpA)) have been reported to have poorer pregnancy outcomes than the…
  • Abstract Number: 0369 • ACR Convergence 2021

    High Frequency of Complications in Axial Spondyloarthropathy Pregnancies: Emerging Data from the Ankylosing Spondylitis Registry of Ireland

    Sinead Maguire1, Phil Gallagher2 and Finbar (Barry) O'Shea1, 1St James's Hospital, Dublin, Ireland, 2St Vincent's Hospital, Dublin, Ireland

    Background/Purpose: National registries are excellent sources of data to allow analysis of inflammatory arthritis such as axial spondyloarthropathy (axSpA). Our understanding of axSpA has evolved…
  • Abstract Number: 1725 • ACR Convergence 2021

    Higher Prevalence of Aspirin Use with a Specific Educational Tool in SLE Pregnancies: Preliminary Results

    Joo Young (Esther) Lee1, Arielle Mendel2, Isabelle Malhamé2, Sasha Bernatsky1 and Evelyne Vinet3, 1McGill University, Montréal, QC, Canada, 2McGill University Health Centre, Montréal, QC, Canada, 3McGill University Health Centre, Mont Royal, QC, Canada

    Background/Purpose: Pregnant women with SLE are at substantial risk of preeclampsia. Best international practice guidelines recommend aspirin (ASA) in this population, as it reduces preeclampsia…
  • Abstract Number: 0619 • ACR Convergence 2021

    Racial and Ethnic Disparities in Pregnancy Outcomes Among Women with Rheumatic Diseases: A Systematic Literature Review and Quantitative Analysis

    Maya Swaminathan1, Gloria Shen2, Irvin Huang2, Diana Louden2, Waqas Tahir3 and Namrata Singh4, 1MultiCare Good Samaritan Hospital, Newcastle, WA, 2University of Washington, Seattle, WA, 3Rochester General Hospital, Rochester, MN, 4University of Washington, Bellevue, WA

    Background/Purpose: Women are disproportionately affected by rheumatic diseases (RD), with many of them carrying the diagnosis in their childbearing years. Pregnant women with RD have…
  • Abstract Number: 1726 • ACR Convergence 2021

    A Pregnancy Planning Quality Score to Assess a Systematic Intervention to Improve Pregnancy Planning for Women with SLE

    Catherine Sims1, Amanda Eudy1, Jayanth Doss1, Lisa Criscione-Schreiber2, Kai Sun2, Rebecca Sadun1, Jennifer Rogers2 and Megan Clowse3, 1Duke University, Durham, NC, 2Duke University School of Medicine, Durham, NC, 3Duke University, Chapel Hill, NC

    Background/Purpose: The safest pregnancies for women with SLE coincide with periods of disease quiescence maintained by pregnancy-compatible medications. In the US, Black women are more…
  • Abstract Number: 1034 • ACR Convergence 2021

    Racial/ethnic Differences in Lupus Pregnancy Outcomes over 1 Decade: A US National Study

    Bella Mehta1, Yiming Luo2, Deanna Jannat-Khah3, Jiehui Xu4, Lisa Sammaritano3, Jane Salmon3, Michael Lockshin1, Susan Goodman3 and Said Ibrahim5, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2National Institutes of Health, Bethesda, MD, 3Hospital for Special Surgery, New York, NY, 4Weill Cornell Medicine, New York, NY, 5Weill Cornell Medicine, Cleveland, OH

    Background/Purpose: Systemic lupus erythematosus (SLE) disproportionately affects women and minorities of childbearing age. Although maternal and fetal outcomes of pregnancy among women with SLE have…
  • Abstract Number: 1727 • ACR Convergence 2021

    Behcet’s Disease: A Meta-analysis of Pregnancy Outcomes

    Leah Rooney1, Aine Gorman2, Matthew Turk3, Louise Moore4, Celine O'Brien5, Jared Bierbrier6, Anne Clohessy5, Eamonn Molloy7, Lorraine O Neill8, Fionnuala M. Mc Auliffe5 and Douglas Veale9, 1St Vincent's University Hospital, Dublin, Ireland, 2St Vincents Hospital, Dublin, Ireland, 3St. Vincents University Hospital, Dublin, Ireland, 4Our Lady's Hospice and Care Services, Harold's Cross, Dublin 6W, Kinnegad, Ireland, 5Perinatal Research Centre, Obstetrics and Gynaecology, School of Medicine, University College Dublin and National Maternity Hospital, Dublin, Dublin, Ireland, 6McMaster University, Hamilton, ON, Canada, 7St Vincent's Healthcare Group, Dublin, Ireland, 8St. Vincent's Hospital, Dublin, Ireland, 9University College Dublin, Dublin, Ireland

    Background/Purpose: Behcet’s disease is a systemic inflammatory disease which commonly presents with episodes of acute inflammation, oral and genital ulcers, uveitis and skin lesions. It…
  • Abstract Number: 1268 • ACR Convergence 2021

    Predicting Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus: A Comparison of Machine Learning Methods

    Melissa Fazzari1, Marta Guerra2, Jane Salmon2 and Mimi Kim3, 1Albert Einstein College of Medicine, Bronx, NY, 2Hospital for Special Surgery, New York, NY, 3Albert Einstein College of Medicine, Larchmont, NY

    Background/Purpose: Nearly 20% of pregnancies in patients with Systemic lupus erythematosus (SLE) result in an adverse pregnancy outcome (APO); early identification of women with SLE…
  • Abstract Number: 1728 • ACR Convergence 2021

    Takayasu’s Arteritis and Pregnancy: A Meta-analysis

    Aine Gorman1, Leah Rooney2, Matthew Turk1, Louise Moore3, Jared Bierbrier4, Celine O'Brien5, Anne Clohessy6, Eamonn Molloy7, Lorraine O Neill8, Fionnuala McAuliffe9 and Douglas Veale10, 1St Vincents Hospital, Dublin, Ireland, 2St Vincent's University Hospital, Dublin, Ireland, 3Our Lady's Hospice and Care Services, Harold's Cross, Dublin 6W, Kinnegad, Ireland, 4McMaster University, Hamilton, ON, Canada, 5Perinatal Research Centre, Obstetrics and Gynaecology, School of Medicine, University College Dublin and National Maternity Hospital, Dublin, Dublin, Ireland, 6National Maternity Hopistal, Dublin, Ireland, 7St Vincent's Healthcare Group, Dublin, Ireland, 8St. Vincent's Hospital, Dublin, Ireland, 9National Maternity Hopsital Dublin, Dublin, Ireland, 10University College Dublin, Dublin, Ireland

    Background/Purpose: Takayasu’s arteritis is a systemic autoimmune disease characterised by large vessel vasculitis. It usually affects women of childbearing age, with 90% of patients diagnosed…
  • Abstract Number: 1464 • ACR Convergence 2021

    Ambulatory Fetal Heart Rate Monitoring (FHRM) to Surveil Pregnancies at Risk for Congenital Heart Block

    Mala Masson1, Colin Phoon1, Elena Sinkovskaya2, Lisa Howley3, Ruben Acherman4, Majd Makhoul5, Nelangi Pinto6, Miao Chang1, Robert Clancy7, Bailey Drewes8, Bettina Cuneo9 and Jill Buyon7, 1NYU Langone Health, New York, NY, 2East Virginia Medical School, Norfolk, 3Children's Hospitals and Clinics of Minnesota, Minneapolis, MN, 4Sunrise Children's Hospital, Las Vegas, NV, 5UK Kentucky Children's Hospital, Lexington, KY, 6University of Utah, Salt Lake City, UT, 7NYU Grossman School of Medicine, New York, NY, 8CU Anschutz Medical Campus, Aurora, 9Children's Hospital Colorado, Aurora, CO

    Background/Purpose: Congenital Heart Block (CHB) complicates 2% of anti-Ro/SSA antibody positive pregnancies and carries substantial perinatal morbidity and mortality. Almost all survivors require lifelong pacing.…
  • Abstract Number: 1729 • ACR Convergence 2021

    Predicting Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus (SLE) Using 2nd Trimester Estimated Glomerular Filtration Rate (eGFR)

    Anika Lucas1, Amanda Eudy1, Michelle Petri2, Rebecca Fischer-Betz3, Abeer Nabil4, Cecilia Nalli5, Laura Andreoli6, Angela Tincani7, Yair Molad8, Stephen Balevic1 and Megan Clowse9, 1Duke University, Durham, NC, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Uniklinik Dsseldorf, Dsseldorf, Germany, 4University of Cairo, Cairo, Egypt, 5ASST SPEDALI CIVILI DI BRESCIA, Brescia, Italy, 6University of Brescia, Brescia, Italy, 7ASST Spedali Civili-University of Brescia, Gussago, Italy, 8Rabin Medical Center, Beilinson Hospital, and Tel Aviv University, Petah-Tikva, Israel, 9Duke University, Chapel Hill, NC

    Background/Purpose: Women with SLE are at increased risk for adverse maternal and fetal outcomes with increased odds of preeclampsia, hypertension, Cesarean and preterm deliveries, low…
  • Abstract Number: 1465 • ACR Convergence 2021

    Trends in Adverse Pregnancy Outcomes Among Women with Systemic Sclerosis in the United States

    Yumeko Kawano1, Kathleen Kolstad2, Shufeng Li1, Julia Simard3 and Lorinda Chung1, 1Stanford University, Palo Alto, CA, 2University of California Los Angeles, Santa Barbara, CA, 3Stanford School of Medicine, Stanford, CA

    Background/Purpose: Autoimmune connective tissue diseases disproportionately affect women of childbearing age. Systemic sclerosis (SSc) is associated with increased risk of adverse pregnancy outcomes (APO). However,…
  • Abstract Number: 1730 • ACR Convergence 2021

    Disease Activity and Outcome in Pregnancies of Patients with SpA – Data from the German Pregnancy Register RHEKISS

    Anja Weiß1, Christina Bungartz1, Jutta Richter2, Susanna Späthling-Mestekemper3, Xenofon Baraliakos4, Peer Aries5, Rebecca Fischer-Betz6 and Anja Strangfeld7, 1DRFZ, Berlin, Germany, 2Rheumatology and Hiller Research Unit, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany, 3Rheumapraxis München, München, Germany, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 5Rheumatologie in Hamburg, Hamburg, Germany, 6Uniklinik Dsseldorf, Dsseldorf, Germany, 7Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany

    Background/Purpose: SpA is a severe chronic inflammatory disease, which affects quality of life and functional status. It frequently occurs in women of childbearing age. Active…
  • Abstract Number: 1466 • ACR Convergence 2021

    Increased Adverse Maternal Postpartum Outcomes in Systemic Lupus Erythematosus Pregnancies Compared to Controls

    April Barnado, Janie Hubbard, Sarah Green and Sarah Osmundson, Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Studies show increased risks of adverse pregnancy outcomes in SLE patients. Few studies have investigated postpartum outcomes in these patients. Using a large, de-identified…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 19
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology